Other GLP-1/GIP/GCG Triple Agonists in Development Besides retatrutide, several GLP-1/GIP/GCG triple agonists are in early-stage clinical trials (Table 3), though the WL efficacy associated with these medications remains unknown
The unfolded protein response: from stress pathway to homeostatic regulation
Finnrick, an independent peptide testing and supply chain transparency platform, tested seven samples of semaglutide from Amino Amigos between January 14 and March 20 of this year
Key takeaways Retatrutide is still being studied, so there is no FDA-approved dosing schedule yet
Brendan Vermeire is a Mental and Metabolic Health Scientist, Functional Medicine Educator, and Board-Certified Holistic Health Practitioner
High insulin levels in the bloodstream can lead to changes in other hormones, potentially disrupting the normal menstrual pattern